Could Another US FDA Safety Alert Foreshadow Withdrawal Of Intercept’s Ocaliva?

 
• By Sue Sutter
  
Caution warning
US FDA has issued a fourth safety alert related to liver injury for Intercept's Ocaliva. (Shutterstock)

More from Drug Safety

More from Pathways & Standards